Ophthalmology

Genetics, Genomics & Precision Ophthalmology

The integration of genetics and genomics into ophthalmology is revolutionizing the diagnosis and treatment of inherited and complex eye diseases. This track will focus on the role of genetic mutations in conditions such as retinitis pigmentosa, Leber’s congenital amaurosis, Stargardt disease, and age-related macular degeneration. Attendees will gain insight into gene therapy, CRISPR technology, and next-generation sequencing tools that enable targeted therapeutic strategies. Experts will also discuss how precision medicine is helping personalize treatments based on a patient’s genetic makeup and risk profile. The track will cover advances in genetic counseling, ethical considerations, and regulatory challenges in applying genomics in clinical practice. Attendees will explore real-world case studies on gene replacement therapies, stem cell interventions, and pharmacogenomics in ocular pharmacology. With the ongoing development of disease-specific genetic therapies, this session provides essential knowledge for clinicians, researchers, and industry professionals seeking to lead in the next frontier of vision care. It is a key opportunity to understand how molecular diagnostics are shaping a more personalized and predictive future for ophthalmology.